Delivery Order SPE2DE21D7010-SPE2D625F13YF

Award Date 1/6/25
Potential Completion Date 1/27/25
Potential Value $5.1K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order (DO) with a Fixed Price with Economic Price Adjustment pricing type, issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, valued at $10,764.82, is for the reline of open implants, with a period of performance through January 27, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts...
This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract has a value of $1,244.44 and was awarded on December 4, 2024, with a completion date of December 24, 2024. The contract type is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing structure. The contract is for the supply of OSTEOCEL PRO, a specialized spinal...
This federal contract award, valued at $34,971.70, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Fixed Price with Economic Price Adjustment Delivery Order for the reline of open implants, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The contract, valued at $10,243.84, is a delivery order for OSTEOCEL PRO medical devices. The contract is a fixed-price with economic price adjustment, and has an ultimate completion date of January 16, 2025. The contract is not set-aside, indicating it was competitively awarded. Nuvasive, Inc. is a...
This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order (DO) with a Fixed Price with Economic Price Adjustment pricing type and an ultimate completion date of November 22, 2024. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, a for-profit organization that...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of December 27, 2024. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract does not...
This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The contract, valued at $2,860.94, is a delivery order for OSTEOCEL PRO medical devices. It has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 31, 2024. The contract is not associated with any set-aside designation, indicating Nuvasive competed for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The $5,583.02 fixed-price contract with economic price adjustment is for the delivery of various spinal medical devices and instruments, such as SIMPLIFY, MODULUS, RELINE MAS IMPLANTS, OSTEOCEL PRO, and COROENT SMALL INTERLOCK. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank...
The U.S. Defense Logistics Agency (DLA) has awarded a $10,383.60 fixed-price delivery order contract to Nuvasive, Inc., a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. This contract is for the procurement of specialized spinal medical devices and surgical equipment, primarily to support orthopedic, neurological, and reconstructive surgeries at Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The contract has an ultimate...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The $1,072.80 delivery order contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of August 27, 2024. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, which also supplies surgical implants and...
  • SPE2DE21D7010
    Indefinite Delivery Contract
  • SPE2DE21D7010-SPE2D625F13YF
    Delivery Order

This federal contract award to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain. The $5,121.92 fixed-price delivery order contract, with economic price adjustment, is for OSTEOCEL PRO medical devices. The contract has an ultimate completion date of January 27, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit organization. The contract is not associated with any set-aside designation, indicating Nuvasive, Inc. competes in open market procurement. This contract award is part of a larger $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency (DHA), which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle allowing DHA facilities to access Nuvasive's portfolio of spinal medical devices and instruments through streamlined ordering.

Generated 4/7/25, 10:45 AM